Choosing Wisely for Better Health Outcomes, Awanui’s New Allergy e-ordering solution
Key take-home messages
- Order allergy tests only when the history suggests an immune, IgE-mediated condition and the result will change management.
- Avoid broad or indiscriminate panels. Sensitisation without clinical allergy is common and can lead to unnecessary restrictions and harm.
- In primary care, limit orders to common, clinically relevant allergens.
- For skin prick testing, the eligible requester is also the prescriber. Prescriber and patient details must be provided for Section 29B records.
New Zealand has a high burden of allergic disease. Because asthma, eczema and allergic rhinitis are common, clinicians need a practical approach to when allergy testing helps diagnosis and management – and when it does not. To assist this, Awanui is launching a new e-order platform to enable this based on the principles of testing outlined below.
Go-live date: Monday 7th December A video tutorial on how to use the e-ordering solution is available here.
Principle 1 – Test only in the appropriate clinical context
Practice points
- Start with the history: allergy testing is indicated only when the reaction is immune-mediated and IgE-mediated, such as rhinitis, acute urticaria, anaphylaxis or asthma.
- Do not test when symptoms are more consistent with other diagnoses, including irritable bowel syndrome, food aversion, vasovagal reactions, vocal cord dysfunction, drug side effects, delayed hypersensitivity or other mechanisms.
- Avoid food allergy testing for eczema, eosinophilic oesophagitis, irritable bowel syndrome and oral allergy syndrome. For oral allergy syndrome, birch pollen testing can support the diagnosis; food-specific testing does not predict which foods will trigger symptoms.
- For aeroallergens, testing is mainly for persistent, recurrent and severe rhinitis that is not controlled with standard therapy.
- For foods, test only when there is an immediate reaction history and the patient is avoiding the food. Keep tolerated foods in the diet.
Principle 2 – Use one modality per allergen: serum-specific IgE or skin prick testing
Practice points
- Do not order both serum-specific IgE and skin prick testing for the same allergen. Choose one.
- Select the modality using patient factors, access, cost, resource availability and patient preference.
- Consider serum-specific IgE where patients cannot stop antihistamines, have dermographism or significant skin disease, face transport or appointment barriers, or need testing for an allergen not available by skin prick testing.
Principle 3 – In primary care, limit testing to common clinically relevant allergens
Practice points
- Order tests only for common, clinically relevant allergens, based on the patient history and local epidemiology.
- Limit aeroallergen testing to a maximum of seven individual allergens.
- Limit food allergen testing to a maximum of three individual allergens.
- Discuss expanded panels or rarer allergens with a relevant specialist or immunopathologist, or order through an approved health pathway.
- Remember: positive tests without clinical allergy – sensitisation – occur about five times more commonly than true allergy. Always interpret results alongside history and symptoms.
Primary care allergen testing guide
| Ordering area | Recommended primary care approach |
| Aeroallergens in primary care | House dust mite; grass mix; cat; dog; birch; plantain; mould mix. |
| Food allergens in primary care | Peanut; wheat; milk; egg; soy; tree nuts (almond, Brazil nut, cashew, hazelnut, macadamia, pecan nut, pistachio, walnut); seafood (codfish, shrimp, mussel, lobster, oyster, tuna, salmon, crab, scallop). |
| Maximum number of allergens | Aeroallergens: maximum of 7 individual allergens. Food allergens: maximum of 3 individual allergens. |
| Access to broader testing | Approval from doctors with allergy knowledge, including clinical immunologists, immunopathologists, allergists, paediatricians and GPs with extended roles in allergy.Health Pathways.GPs who have completed approved training modules or programmes in allergy. |
E-ordering for specialists:
For those with formal training in allergy, there will be a separate ordering solution which will allow for more extended allergy testing. This will require pathologist approval. Please contact the laboratory if you would like to apply for this. Approval will require evidence of formal training in allergy.
Skin prick testing: prescribing and Section 29B requirements
Your request is also a prescription
The allergen products used by Awanui for skin prick testing are unapproved medicines. When you request skin prick testing as an eligible Section 29 prescriber, you are the prescriber authorising the allergen products used for your patient. Awanui will rely on the request form, including the e-order, as the prescription for this purpose.
As part of the consent process, patients are informed of the Section 29 requirements
Information supplied and retained
To support compliance with Section 29B of the Medicines Act 1981, Awanui will provide the distributor or supplier of the allergen products with the following information, as applicable:
- The requester’s name and professional details, as the prescriber, and the patient’s name.
- The Awanui testing laboratory location and the request or testing date.
- The allergen product name and the quantity supplied.
The supplier is required to retain this information, including the prescriber’s and patient’s names.
The New Zealand importer or manufacturer is responsible for providing the required monthly supply information to Medsafe. Patient and prescriber names are not included in this routine monthly report.
Awanui | Choosing Wisely for better health outcomes